![]() RS Research RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy. | ||||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 1978 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Cambridge, US HQ Toronto, CA New York, US Stony Brook, US | Locations Woburn, US HQ Milton, GB Woburn, US | Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more | Locations Epalinges, CH HQ |
Employees | Employees 6526% decrease | Employees 10422% increase | Employees 16,315 | Employees 254% decrease |
Valuation ($) | Valuation ($) 165 m | Valuation ($) 823.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($82.4m) (FY, 2023) | Net income ($215.8m) (FY, 2024) | Net income ₹13b (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 202.1m | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A |
Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View companyRS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
View company